Literature DB >> 16251198

Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes.

Samuel Deutsch1, Robert Lyle, Emmanouil T Dermitzakis, Homa Attar, Lakshman Subrahmanyan, Corinne Gehrig, Leila Parand, Maryline Gagnebin, Jacques Rougemont, C Victor Jongeneel, Stylianos E Antonarakis.   

Abstract

Inter-individual differences in gene expression are likely to account for an important fraction of phenotypic differences, including susceptibility to common disorders. Recent studies have shown extensive variation in gene expression levels in humans and other organisms, and that a fraction of this variation is under genetic control. We investigated the patterns of gene expression variation in a 25 Mb region of human chromosome 21, which has been associated with many Down syndrome (DS) phenotypes. Taqman real-time PCR was used to measure expression variation of 41 genes in lymphoblastoid cells of 40 unrelated individuals. For 25 genes found to be differentially expressed, additional analysis was performed in 10 CEPH families to determine heritabilities and map loci harboring regulatory variation. Seventy-six percent of the differentially expressed genes had significant heritabilities, and genomewide linkage analysis led to the identification of significant eQTLs for nine genes. Most eQTLs were in trans, with the best result (P=7.46 x 10(-8)) obtained for TMEM1 on chromosome 12q24.33. A cis-eQTL identified for CCT8 was validated by performing an association study in 60 individuals from the HapMap project. SNP rs965951 located within CCT8 was found to be significantly associated with its expression levels (P=2.5 x 10(-5)) confirming cis-regulatory variation. The results of our study provide a representative view of expression variation of chromosome 21 genes, identify loci involved in their regulation and suggest that genes, for which expression differences are significantly larger than 1.5-fold in control samples, are unlikely to be involved in DS-phenotypes present in all affected individuals.

Entities:  

Mesh:

Year:  2005        PMID: 16251198     DOI: 10.1093/hmg/ddi404

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  eQTL analysis links inflammatory bowel disease associated 1q21 locus to ECM1 gene.

Authors:  Katja Repnik; Uroš Potočnik
Journal:  J Appl Genet       Date:  2016-01-06       Impact factor: 3.240

3.  An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.

Authors:  Giovanna Cenini; Ada Fiorini; Rukhsana Sultana; Marzia Perluigi; Jian Cai; Jon B Klein; Elizabeth Head; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-08-20       Impact factor: 7.376

4.  Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes.

Authors:  Giuseppe Merla; Cédric Howald; Charlotte N Henrichsen; Robert Lyle; Carine Wyss; Marie-Thérèse Zabot; Stylianos E Antonarakis; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2006-06-23       Impact factor: 11.025

Review 5.  Genetic variation in human gene expression.

Authors:  Emmanouil T Dermitzakis; Barbara E Stranger
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

Review 6.  The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Authors:  Avi Ma'ayan; Katheleen Gardiner; Ravi Iyengar
Journal:  NeuroRx       Date:  2006-07

7.  Gene expression variation increase in trisomy 21 tissues.

Authors:  Ching Yu Chou; Li Yu Liu; Chien Yu Chen; Cheng Hsien Tsai; Hsiao Lin Hwa; Li Yun Chang; Yi Shing Lin; Fon Jou Hsieh
Journal:  Mamm Genome       Date:  2008-07-02       Impact factor: 2.957

8.  Genetic architecture of transcript-level variation in humans.

Authors:  Shiwei Duan; R Stephanie Huang; Wei Zhang; Wasim K Bleibel; Cheryl A Roe; Tyson A Clark; Tina X Chen; Anthony C Schweitzer; John E Blume; Nancy J Cox; M Eileen Dolan
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

9.  Genetic variants contributing to daunorubicin-induced cytotoxicity.

Authors:  R Stephanie Huang; Shiwei Duan; Emily O Kistner; Wasim K Bleibel; Shannon M Delaney; Donna L Fackenthal; Soma Das; M Eileen Dolan
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

10.  Explaining inter-individual variability in phenotype: is epigenetics up to the challenge?

Authors:  Nahid Turan; Sunita Katari; Christos Coutifaris; Carmen Sapienza
Journal:  Epigenetics       Date:  2010-01-06       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.